108 related articles for article (PubMed ID: 20222844)
1. Hormone therapy affects plasma measures of factor VII-activating protease in younger postmenopausal women.
Sidelmann JJ; Skouby SO; Vitzthum F; Schwarz H; Jespersen J
Climacteric; 2010 Aug; 13(4):340-6. PubMed ID: 20222844
[TBL] [Abstract][Full Text] [Related]
2. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
Keramaris NC; Christodoulakos GE; Lambrinoudaki IV; Dalamanga A; Alexandrou AP; Bramis J; Bastounis E; Creatsas GC
Climacteric; 2007 Oct; 10(5):400-7. PubMed ID: 17852143
[TBL] [Abstract][Full Text] [Related]
3. Effects of postmenopausal hormone replacement therapy on body fat composition.
Yüksel H; Odabasi AR; Demircan S; Köseoğlu K; Kizilkaya K; Onur E
Gynecol Endocrinol; 2007 Feb; 23(2):99-104. PubMed ID: 17454160
[TBL] [Abstract][Full Text] [Related]
4. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
[TBL] [Abstract][Full Text] [Related]
5. Plasma factor VII-activating protease is increased by oral contraceptives and induces factor VII activation in-vivo.
Sidelmann JJ; Skouby SO; Kluft C; Winkler U; Vitzthum F; Schwarz H; Gram J; Jespersen J
Thromb Res; 2011 Nov; 128(5):e67-72. PubMed ID: 21737124
[TBL] [Abstract][Full Text] [Related]
6. B-type natriuretic peptide after hormone therapy in postmenopausal women with chest pain and normal coronary angiogram.
Kawano H; Nagayoshi Y; Soejima H; Tanaka Y; Hokamaki J; Miyamoto S; Miyazaki Y; Yamabe H; Ogawa H
Menopause; 2008; 15(2):352-6. PubMed ID: 18090872
[TBL] [Abstract][Full Text] [Related]
7. Factor seven ativating potease (FSAP) levels during normal pregnancy and in women using oral contraceptives.
Parahuleva MS; Hölschermann H; Erdogan A; Langanke E; Prickartz I; Parviz B; Weiskirchen R; Tillmanns H; Kanse SM
Thromb Res; 2010 Jul; 126(1):e36-40. PubMed ID: 20381831
[TBL] [Abstract][Full Text] [Related]
8. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.
Yeboah J; Klein K; Brosnihan B; Reboussin D; Herrington DM
Menopause; 2008; 15(6):1060-4. PubMed ID: 18521047
[TBL] [Abstract][Full Text] [Related]
9. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
[TBL] [Abstract][Full Text] [Related]
10. Effect of abrupt discontinuation versus gradual dose reduction of postmenopausal hormone therapy on hot flushes.
Cunha EP; Azevedo LH; Pompei LM; Strufaldi R; Steiner ML; Ferreira JA; Peixoto S; Fernandes CE
Climacteric; 2010 Aug; 13(4):362-7. PubMed ID: 20151792
[TBL] [Abstract][Full Text] [Related]
11. Comparison of effects of pravastatin and hormone therapy on soluble P-selectin and platelet P-selectin expression in postmenopausal hypercholesterolemic women.
Peverill RE; Smolich JJ; Malan E; Goldstat R; Davis SR
Maturitas; 2006 Jan; 53(2):158-65. PubMed ID: 16368469
[TBL] [Abstract][Full Text] [Related]
12. Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy.
Ylikorkala O; Lim P; Caubel P
Clin Ther; 2000 May; 22(5):622-36. PubMed ID: 10868559
[TBL] [Abstract][Full Text] [Related]
13. Factor VII-activating protease in patients with acute deep venous thrombosis.
Sidelmann JJ; Vitzthum F; Funding E; Münster AM; Gram J; Jespersen J
Thromb Res; 2008; 122(6):848-53. PubMed ID: 18394684
[TBL] [Abstract][Full Text] [Related]
14. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
[TBL] [Abstract][Full Text] [Related]
15. The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis.
Eilertsen AL; Høibraaten E; Os I; Andersen TO; Sandvik L; Sandset PM
Maturitas; 2005 Oct; 52(2):111-8. PubMed ID: 16186073
[TBL] [Abstract][Full Text] [Related]
16. Hemostatic markers in healthy postmenopausal women during intranasal and oral hormone therapy: a randomized trial.
Hemelaar M; Kenemans P; Hack CE; Klipping C; van der Mooren MJ
Menopause; 2008; 15(2):248-55. PubMed ID: 17693902
[TBL] [Abstract][Full Text] [Related]
17. Effect of hormone therapy on the enteroinsular axis.
Sztefko K; Rogatko I; Milewicz T; Józef K; Tomasik PJ; Szafran Z
Menopause; 2005; 12(5):630-638. PubMed ID: 16145319
[TBL] [Abstract][Full Text] [Related]
18. The effect of low dose hormone therapy on mammographic breast density.
Christodoulakos GE; Lambrinoudaki IV; Vourtsi AD; Vlachou S; Creatsa M; Panoulis KP; Botsis D
Maturitas; 2006 Apr; 54(1):78-85. PubMed ID: 16198519
[TBL] [Abstract][Full Text] [Related]
19. Early postmenopausal hormone therapy improves postural balance.
Naessen T; Lindmark B; Lagerström C; Larsen HC; Persson I
Menopause; 2007; 14(1):14-9. PubMed ID: 17091024
[TBL] [Abstract][Full Text] [Related]
20. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
Grodstein F; Manson JE; Stampfer MJ
J Womens Health (Larchmt); 2006; 15(1):35-44. PubMed ID: 16417416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
